As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...

CAD (NASDAQ:ICAD) (market cap: $85.26M), a leader in AI-powered breast cancer detection, reported its third-quarter 2024 financial results, demonstrating a 4% year-over-year increase in revenue to $4.

Her employer said a contract is only ended when "all other options have been exhausted and a robust process has been followed" ...

The brave woman opened up about her initial diagnosis, years of treatment, feeling guilty, family support, and how she thinks ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

Advice from the US surgeon general is consistent with the evidence but repeatedly opposed by commercial actors, says Nason Maani A recent advisory report from the outgoing US surgeon general, Vivek ...

Actress Rozlyn Khan has now made new claims against Hina Khan and even accused the latter of 'bribing her doctors' to hide ...

Carrie's TOUCH presents 'Dinner with the Youngers,' a live reading of Lorraine Hansberry's 'A Raisin in the Sun,' to raise ...

The Minette’s Angels Foundation will hold its spring fundraising brunch at the Glen Ridge Country Club on Sunday, May 4, from ...

AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

Lily Wofford, a champion barrel racer from Vilonia, is sharing her story of strength and resilience after being diagnosed with cancer.